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Edited by Beat ImhofAbstract Mutations in WNK4 have been linked to hypertension
in PHAII. Paracellular ion transport has been reported to be in-
volved in this disease process; however, the speciﬁc molecular
target has not been identiﬁed. In this study, we found that TJ
protein claudin-7 and WNK4 were partially co-localized in renal
tubules of rat kidney and co-immunoprecipitated in kidney epi-
thelial cells. The wild-type and PHAII-causing mutant, but not
the kinase-dead mutant, phosphorylated claudin-7. We have
identiﬁed ser206 in the COOH-terminus of claudin-7 as a puta-
tive phosphorylation site for WNK4. More importantly, dis-
ease-causing mutant enhanced claudin-7 phosphorylation and
signiﬁcantly increased paracellular permeability to Cl.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Pseudohypoaldosteronism type II (PHAII) is a rare autoso-
mal dominant disease characterized by hypertension, hyper-
kalaemia, and hyperchloraemic acidosis without renal failure
[1]. Using the positional cloning method, PHAII has been
linked to the mutations in WNK4, a serine/threonine kinase
with no K (=lysine) in the kinase domain [2]. In the kidney,
WNK4 kinase is localized at tight junctions (TJs) of the distal
convoluted tubule (DCT) and collecting duct (CD) [2]. It has
been proposed that the hypertension and hyperkalemia pheno-
types seen in PHAII are chloride-dependent and caused by the
increased chloride reabsorption in renal distal tubules [3].
Although the precise molecular mechanism for how muta-
tions in WNK4 can cause hypertension is still under investiga-
tion, many studies have shown that several membrane
channels and transporters are potential molecular targets of
WNK4 [4–7]. Since WNK4 is speciﬁcally localized at TJs of
distal nephrons, TJ proteins could also serve as additional tar-Abbreviations: PHAII, pseudohypoaldosteronism type II; TJ, tight
junction; TER, transepithelial electrical resistance
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doi:10.1016/j.febslet.2007.07.014gets for WNK4. Recently, two groups [8,9] have reported that
WNK4 regulates the paracellular Cl permeability in MDCK
II cells, and the expression of PHAII-causing mutant WNK4-
D564A and WNK4-Q562E in MDCK II cells resulted in an in-
creased paracellular Cl permeability compared to that of
wild-type WNK4 expression. By co-transfection of claudins
and WNK4 into MDCK II cells, Yamauchi et al. [8] showed
that TJ proteins, claudin-1, -2, -3, and -4, could be phosphor-
ylated by WNK4 kinase.
Although it has been demonstrated that WNK4 regulates
paracellular Cl permeability in kidney epithelial cells, the spe-
ciﬁc molecular target is still unclear. Studies from this labora-
tory and by others have suggested that claudin-7 is involved in
the regulation of paracellular Cl permeation [10,11]. There-
fore, claudin-7 is more likely a speciﬁc TJ target for WNK4.
In this study, we report that claudin-7 interacts with WNK4
and is phosphorylated by WNK4 at ser206 in its COOH-termi-
nus. Moreover, disease-causing mutant increases claudin-7
phosphorylation and paracellular permeability to Cl com-
pared to controls. Therefore, regulation of paracellular ion ﬂux
by WNK4 through claudin-7 phosphorylation could be an-
other molecular mechanism controlling the ionic balance in
the body.2. Materials and methods
2.1. Generation of anti-WNK4 antibody
Two rabbit anti-WNK4 antibodies were generated against peptide
sequences corresponding to mouse WNK4 amino acids 40–56 and
989–1008 (#71 and #72, 21st Century Biochemicals). The sera from
diﬀerent bleeds were tested on LLC-PK1 cells (a kidney epithelial cell
line) transfected with WNK4 cDNA using the Western blotting meth-
od. The sera with strong anti-WNK4 immunoreactivity signals were
pulled together and aﬃnity puriﬁed. An aliquot of rabbit anti-
WNK4 was a generous gift from Dr. D.H. Ellison of Oregon Health
and Science University [4] and served as a positive control. Unless
otherwise indicated, the anti-WNK4 antibody used in this study is #72.2.2. Generation of mutations by site-directed mutagenesis and amino acid
replacement in PCR primers
The full lengthWNK4 cDNA (in pcDNA3.1 vector, kindly provided
by Dr. D.H. Ellison) was used as a template to generate WNK4-Q562E
and WNK4-D318A using the QuikChange site-directed mutagenesis
kit (Stratagene). Speciﬁc HPLC puriﬁed oligonucleotide primer pairs
were synthesized by IDT, Inc.
Claudin-7 phosphorylation null mutations were generated by replac-
ing serine with alanine at position 204 (S204A), 206 (S206A), and 207
(S207A) in antisense primers. All the mutations were conﬁrmed by
DNA sequencing (ECU Genomic Core Facility).blished by Elsevier B.V. All rights reserved.
Fig. 1. Characterization of anti-WNK4 antibodies. (A) Rabbit anti-
WNK4 #71 and #72 antibodies, along with a pre-immune control,
were tested on LLC-PK1 cells transfected with WNK4 cDNA (2) or
vector alone (1). The other anti-WNK4 antibody was used as a positive
control. All antibodies were diluted at 1:500. (B) LLC-PK1 cells
transfected with WNK4 cDNA (2) or vector alone (1) were lysed in
RIPA buﬀer without SDS and immunoprecipitated (IP) with #72 or
3888 R. Tatum et al. / FEBS Letters 581 (2007) 3887–38912.3. Transfections, immunoprecipitation, and in vitro kinase assay
LLC-PKl cells grown to 80–90% conﬂuence were transfected with
diﬀerent constructs using Lipofectamine 2000 (Invitrogen). After
48 h, transfected cells were lysed, and the protein concentration of each
cell lysate was determined using the BCA protein assay kit (Pierce).
Cell lysates with equal amount of total protein were immunoprecipi-
tated using speciﬁc antibodies (see ﬁgure legends for individual exper-
iments). The immunoprecipitates were captured by protein A or G
beads. The beads containing the substrate (claudin-7 or its mutant)
were then combined with the beads containing protein kinase
(WNK4 or its mutant) in a kinase reaction buﬀer (10 mM MgCl2,
5 mM benzamidine, 1 mM dithiothreitol, 30 mM HEPES, pH 7.2).
The kinase reaction was carried out at 30 C for 30 min in the presence
of 2 lCi [c-32P] ATP and 150 lM cold ATP. The samples were resolved
by SDS–PAGE, and phosphorylated proteins were visualized by auto-
radiography.
2.4. Electrophysiological measurements
Dilution potential measurements were performed using cell mono-
layers grown on Transwell membranes as described previously [10].
The apical and basal chambers were ﬁlled with P1 buﬀer containing
(in mM): 140 NaCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose
(pH 7.3). To measure the dilution potential, the basal chamber was
switched from P1 to P2 buﬀer containing (in mM): 70 NaCl, 140 man-
nitol, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose (pH 7.3). During
the experiments, the buﬀer was maintained at 37 C and bubbled con-
stantly with 95% air – 5% CO2. The ion permeability ratio for the cell
monolayer was calculated from the dilution potentials using the Gold-
man–Hodgkin–Katz equation [11,12]. Statistical analysis was per-
formed using Origin50 and VassarStats programs. Diﬀerences
between the means of each group were tested for statistical signiﬁcance
(P < 0.05) using one-way ANOVA followed by the Tukey post-test.anti-WNK4 antibody. The membrane was then blotted using #72
antibody. The arrowhead in A and B indicates the WNK4 signal.
Fig. 2. (A) Localization of claudin-7 and WNK4 in rat kidney cortex.
Frozen sections of rat kidney cortex were ﬁxed in 100% methanol and
double-immunostained with mouse anti-claudin-7 mAb (Zymed) (a)
and rabbit anti-WNK4 pAb (b). Arrows indicate the same cells in a
and b. Bar, 20 lm. (B) Co-immunoprecipitation of claudin-7 and
WNK4. LLC-PK1 cells were transfected with WNK4 cDNA (2 and 4)
or vector alone (1 and 3). Claudin-7 was immunoprecipitated using
anti-claudin-7 antibody. Proteins were revealed by Western blotting
using anti-WNK4 antibody. Cell lysates were served as a control for
WNK4 signal.3. Results
3.1. Characterization of anti-WNK4 antibody
We have raised two rabbit anti-WNK4 antibodies (#71 and
#72) that recognize human, mouse, and rat WNK4 peptide se-
quences: one against the NH2-terminus of the molecule and the
other to the COOH-terminus of the molecule. The character-
ization of these two antibodies using western blots showed that
both #71 and #72 antibodies recognized WNK4 in the WNK4
transfected LLC-PK1 cells but not in the mock transfected
cells (Fig. 1A). To test whether our anti-WNK4 antibody
can be used for immunoprecipitation experiments, we immu-
noprecipitated WNK4 from LLC-PK1 cells transfected with
WNK4 cDNA or vector alone using #72 antibody. We found
that WNK4 can be eﬀectively pulled down by #72 in WNK4
transfected cells as indicated by the arrowhead in Fig. 1B.
3.2. Phosphorylation of claudin-7 at ser206 by WNK4 kinase
Claudin-7 and WNK4 are both localized in DCT and CD in
kidneys [2,10,13]. Using the double-immunoﬂuorescent stain-
ing method, we showed that claudin-7 and WNK4 were par-
tially co-localized to the epithelial cells of the renal tubule in
rat kidney cortex (Fig. 2A). To examine whether claudin-7
and WNK4 interact with each other, claudin-7 was immuno-
precipitated from LLC-PK1 cells transfected with WNK4
cDNA or vector alone using anti-claudin-7 antibody. As re-
vealed by Fig. 2B, WNK4 was present in the claudin-7 immu-
noprecipitates. This demonstrates that WNK4 and claudin-7
form a protein complex when they are co-expressed in culture.
To examine whether claudin-7 is the substrate of WNK4 and
to identify its potential phosphorylation site(s), we made three
claudin-7 phosphorylation null mutations by PCR. M3 mutant
had three serine mutations, S204A, S206A, and S207A. M2
mutant contained S206A and S207A mutations and M1 mu-
tant contained a single S207A mutation as illustrated in
Fig. 3. Identiﬁcation of claudin-7 phosphorylation site(s) by WNK4
kinase. (A) Three serine residues at position 204, 206, and 207 were
replaced by alanine to create phosphorylation null mutations. (B)
Claudin-7 mutants, M3 (S204A/S206A/S207A), M2 (S206A/S207A),
and M1 (S207A), as well as WT construct were transfected into LLC-
PK1 cells individually. These transfected cells were lysed in RIPA
buﬀer without phosphatase inhibitors. Claudin-7 WT and mutants
were immunoprecipitated by anti-myc antibody and captured by
protein G beads. These four samples were then individually incubated
with protein A beads containing WNK4 immunoprecipitates obtained
from WNK4 transfected cells before performing in vitro kinase assay.
This autoradiograph is a representative of three independent experi-
ments. The arrowhead indicates the lane loaded with the pre-stained
molecular weight marker that is not radioactive. The arrow shows the
claudin-7 radioactive band.
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7 were all myc-tagged to distinguish them from the endoge-
nous claudin-7 expressed in LLC-PK1 cells. As demonstrated
in Fig. 3B, wild-type claudin-7 (WT) was phosphorylated by
WNK4 in the in vitro kinase assay. However, M3 mutant
was not phosphorylated by WNK4, suggesting that ser204,
ser206, and ser207 are the potential sites for WNK4 phosphor-
ylation. In addition, M2 was also not phosphorylated in the
presence of WNK4, indicating that ser204 was not phosphory-
lated by WNK4. The fact that M1 was phosphorylated by
WNK4 indicated ser206 as a putative phosphorylation site for
WNK4.
3.3. Disease-causing mutant enhanced claudin-7 phosphorylation
and increased paracellular Clpermeability
To study the eﬀect of disease-causing mutant on claudin-7
phosphorylation, the point mutation Q562E was made by
site-directed mutagenesis. As a negative control, we also gener-
ated a kinase-dead mutant D318A. In Fig. 4A, besides the con-
ﬁrmation of claudin-7 as the substrate of WNK4 (WT), it
showed, more importantly, that the claudin-7 phosphorylation
signal was enhanced by WNK4-Q562E (Q) and diminished by
WNK4-D318A (D). There was no claudin-7 phosphorylation
in mock transfected cells ().
To examine the eﬀect of WNK4 and its disease-causing mu-
tant on TJ barrier function, we measured the transepithelial
electrical resistance (TER) on LLC-PK1 cells transfected withthe vector, claudin-7, claudin-7/WNK4-WT, or claudin-7/
WNK4-Q562E (Fig. 4B). Overexpression of claudin-7 greatly
increased TER (lane 2) compared to that of mock transfected
cells (lane 1), as we reported previously [10]. Co-transfection of
claudin-7 and WNK4-WT dramatically decreased TER in the
presence of 140 mM NaCl compared to that of claudin-7 trans-
fected cells (lane 3). Co-transfection of claudin-7 and disease-
causing mutant (WNK4-Q) further decreased its TER (lane
4). To determine the paracellular ion selectivity, dilution
potentials were measured on transfected cells. As shown in
Fig. 4C, dilution potentials were signiﬁcantly increased for
the cells co-transfected with claudin-7/WNK4-WT (lane 2)
compared to that of cells transfected with claudin-7 (lane 1).
In addition, the cells expressing claudin-7/WNK4-Q had higher
dilution potential values compared to the cells expressing clau-
din-7/WNK4-WT (lane 3). The ion permeability ratio (PCl/PNa)
calculated from the dilution potentials indicated that cells
expressing WNK4-Q562E had higher paracellular Cl perme-
ability compared to the cells without WNK4 expression or
expressing wild-type WNK4 (Fig. 4D).4. Discussion
WNK4 mutations cause hypertension in PHAII featured by
excessive Na+, Cl, and K+ retention in the blood. Besides
NCC, ROMK, and ENaC that have been reported as the
molecular targets of WNK4, alteration of paracellular ion per-
meation has also been proposed as a contributing factor to the
pathogenesis of PHAII [14,15]. However, the speciﬁc paracel-
lular molecular target for WNK4 is unclear. In this study,
we report that claudin-7 and WNK4 are partially co-localized
in renal tubules of rat kidney and can be co-immunoprecipi-
tated when both are expressed in kidney epithelial cells.
WNK4 phosphorylates claudin-7 and ser206 in the COOH-ter-
minus of claudin-7 is a putative phosphorylation site for
WNK4.
The COOH-terminus of claudin-7 contains ﬁve serine resi-
dues with no threonine. Three serine residues at position
204, 206, and 207 are clustered together and can potentially
be phosphorylated by WNK4 kinase. By making triple muta-
tions, double mutations, and a single mutation, we found that
mutants with triple mutations (S204A/S206A/S207A) or dou-
ble mutations (S206A/S207A) were not phosphorylated by
WNK4, suggesting that ser206 and ser207 are the potential sites
for WNK4 phosphorylation. However, since the mutant carry-
ing S207A single mutation was phosphorylated by WNK4, we
conclude that at least one serine residue, ser206, is phosphory-
lated by WNK4.
We have co-transfected claudin-7 with WNK4 or its disease-
causing mutant into LLC-PK1 cells. Co-transfection of clau-
din-7 and WNK4 allowed us to see the WNK4 eﬀect on clau-
din-7 since LLC-PK1 cells also endogenously express
claudin-1, -3, -4, and -7. On the other hand, claudin-7 could
also be potentially phosphorylated by other protein kinases
present in LLC-PK1 cells. Therefore, to obtain de-phosphory-
lated claudin-7 for the in vitro kinase assay we used the clau-
din-7 immunoprecipitation condition that favors claudin-7 to
be de-phosphorylated.
Our studies show that overexpression of claudin-7 decreases
paracellular Cl conductance. We hypothesize that claudin-7
regulation of paracellular Clpermeability could be modulated
Fig. 4. Eﬀects of WNK4-Q562E on claudin-7 phosphorylation and paracellular ion permeability. (A) In vitro kinase assay. WNK4 (WT), Q562E
(Q), D318A (D), or vector alone () constructs were individually transfected into LLC-PK1 cells. Transfected cells were lysed in the buﬀer containing
0.2% NP-40 and 0.1% deoxycholate plus protease and phosphatase inhibitors. WNK4 proteins were immunoprecipitated using anti-WNK4 antibody
and captured by protein A beads. Claudin-7 was immunoprecipitated from LLC-PK1 cells by anti-claudin-7 antibody and captured by protein A
beads. These two beads containing WNK4 and claudin-7 were combined and the in vitro kinase assay experiments were performed. This
autoradiograph is a representative of three separate experiments. (B) TER measurements. LLC-PK1 cells transfected with vector alone (1), claudin-7
(2), claudin-7/WNK4-WT (3), or claudin-7/WNK4-Q562E (4) were grown on Transwell ﬁlters until conﬂuent. TER was measured in the P1 buﬀer. (C,
D) Dilution potential measurements and ion permeability ratio calculation. LLC-PK1 cells transfected with claudin-7 (1), claudin-7/WNK4-WT (2),
or claudin-7/WNK4-Q562E (3) were grown on ﬁlters until conﬂuent. Dilution potentials were measured when the basal buﬀer was changed from P1 to
P2 buﬀer. The ion permeability ratio (PCl/PNa) was calculated from dilution potentials. In B, C, and D, data are represented as means ± S.E.M. from
three separate experiments and letters of a, b, and c indicate diﬀerences between groups.
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claudin-7 is phosphorylated, it increases the paracellular con-
ductance to Cl while claudin-7 de-phosphorylation could de-
crease the paracellular Cl permeability. Overexpression of
claudin-7 could saturate the endogenous kinase and cause
the majority of overexpressed claudin-7 to be non-phosphory-
lated. These non-phosphorylated claudin-7 molecules are in-
serted into the membrane, which could decrease the amount
of phosphorylated claudin-7 at TJs, therefore, reduce the para-
cellular conductance to Cl. Phosphorylation of claudin-7 by
WNK4 can lead to a conformation change that favors the
paracellular Cl ﬂux. Another contributing factor could be
protein-protein interactions. Overexpression and/or phosphor-
ylation of claudin-7 could change the interaction of claudin-7
with other TJ proteins, which can alter the paracellular Cl
permeability. Future studies are needed to test these hypothe-
ses.
In summary, our results demonstrate that claudin-7 is a sub-
strate of WNK4, and PHAII-causing mutant WNK4 enhances
claudin-7 phosphorylation and promotes paracellular Clper-
meability. Therefore, claudin-7 could be a potential substrate
of WNK4 in vivo and the enhanced paracellular ion ﬂux by
WNK4 could contribute to hypertension in humans.
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